MGC Pharmaceuticals Overview

  • Founded
  • 2015

Founded
  • Status
  • Public

  • Stock Symbol
  • MXC

Stock Symbol
  • Investments
  • 8

MGC Pharmaceuticals General Information

Description

MGC Pharmaceuticals Ltd is a biopharma company with a Nature to Medicine strategy at the forefront of the emerging phytocannabinoid and plant derived medicine markets. The company's mission is to build an innovative, global bio-pharma company providing standardised, affordable plant derived medicines of the highest regulatory compliance for targeted global markets.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
ASX
Primary Office
  • PO Box 1976
  • West Perth, Western Australia 6872
  • Australia
+61 (08) 0000 0000

MGC Pharmaceuticals Timeline

2019202020212022
Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MGC Pharmaceuticals Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$26.9M 2.87B 2.08M

MGC Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 30-Sep-2022 FY 2022 30-Jun-2022 FY 2021 30-Jun-2021 FY 2020 30-Jun-2020
EV 29,077 29,489 64,914 21,663
Revenue 3,429 2,209 1,393
EBITDA (14,718) (10,873) (12,168)
Net Income (14,745) (11,832) (12,970)
Total Assets 12,766 18,209 5,448
Total Debt 2,994 4,521 1,305
Public Fundamental Data provided by Morningstar, Inc. disclaimer

MGC Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore MGC Pharmaceuticals‘s full profile, request access.

Request a free trial

MGC Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
MGC Pharmaceuticals Ltd is a biopharma company with a Nature to Medicine strategy at the forefront of the emerging phyto
Pharmaceuticals
West Perth, Australia
000.00
000000000 000.00

000000

it in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat
000000000000000
Mumbai, India
00000 As of 0000
00000
000000000 00000

00000

dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ali
0000 000000000
Mumbai, India
00000 As of 0000
00000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MGC Pharmaceuticals Competitors (19)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Glenmark Pharmaceuticals Corporation Mumbai, India 00000 00000 000000000 00000
00000 Corporation Mumbai, India 00000 00000000
000000000000000 00 Corporation Lagos, Nigeria 00
000000 Formerly PE-Backed Bengaluru, India 00000 000.00 00000000 000.00
000000000 000000 Corporation Hyderabad, India 00000 00000 000000000 00000
You’re viewing 5 of 19 competitors. Get the full list »

MGC Pharmaceuticals Executive Team (10)

Name Title Board Seat Contact Info
Yifat Steuer Chief Operating Officer & Deputy Chief Executive Officer
Roby Zomer Chief Executive Officer & Board Member
Sasha Friedman Chief Operational Officer and Deputy CEO
Angela-Marie Graham Chief Financial Officer
Amir Polak Chief Technology Officer
You’re viewing 5 of 10 executive team members. Get the full list »

MGC Pharmaceuticals Board Members (4)

Name Representing Role Since
0000 00000 MGC Pharmaceuticals Board Member 000 0000
00000 00000 MGC Pharmaceuticals Board Member 000 0000
0000 00000 MGC Pharmaceuticals Chief Executive Officer & Board Member 000 0000
0000000 000000 00. MGC Pharmaceuticals Board Member 000 0000
To view MGC Pharmaceuticals’s complete board members history, request access »

MGC Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore MGC Pharmaceuticals‘s full profile, request access.

Request a free trial

MGC Pharmaceuticals Investments & Acquisitions (8)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 00000000 28-Jul-2022 0000000000 00000 Other Healthcare Technology Systems
00000000 21-Apr-2021 0000000000 00.000 Drug Discovery 0000 0000
000000000 000 23-Nov-2020 0000000000 00.000 Clinics/Outpatient Services 0000 0000
000000000 000 25-Aug-2020 00000 0000 Pharmaceuticals 0000 0000
MGC Derma 27-Sep-2018 Secondary Transaction - Private 00000 Personal Products
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

MGC Pharmaceuticals Subsidiaries (2)

Company Name Industry Location Founded
MediCaNL Drug Discovery Zikhron Yaakov, Israel 2019
000000000 00000000 Clinics/Outpatient Services Melbourne, Australia 0000
To view MGC Pharmaceuticals’s complete subsidiaries history, request access »

MGC Pharmaceuticals Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
000 00000 27-Sep-2018 000000000 00000000 00000 Completed
  • 000 00000000000000
000 00000 01-May-2016 00000 0000000 Completed
  • 2 buyers
Erin Mineral Resources 31-May-2012 Merger/Acquisition Completed
To view MGC Pharmaceuticals’s complete exits history, request access »